Oscar Lilleby
University of Copenhagen
Quality of lifeCancerRadiobiologyInternal medicineRadiologyOncologyGenomicsAblative caseProstateBrachytherapyPTENAndrogen deprivation therapyFusion transcriptMetastasisMalignancyProstate cancerGenetic testingLymph nodeHigh-Dose Rate BrachytherapyPsa relapsePsma pet ctPersonalized medicineRadiation therapyTestosteroneMedicine
3Publications
1H-index
2Citations
Publications 4
Newest
#1Sigve NakkenH-Index: 19
#2Wolfgang LillebyH-Index: 18
Last. Eivind HovigH-Index: 56
view all 10 authors...
Guidelines for genetic testing have been established for multiple tumor types, frequently indicating the most confident molecularly targeted treatment options. However, considering the often-complex presentation of individual cancer patients, in addition to the combinatorial complexity and inherent uncertainties of molecular findings, deriving optimal treatment strategies frequently becomes very challenging. Here, we report a comprehensive analysis of a 68-year-old male with metastatic prostate ...
Source
#1Sigve NakkenH-Index: 19
#2Wolfgang LillebyH-Index: 18
Last. Eivind HovigH-Index: 56
view all 10 authors...
Source
#1Ting Martin Ma (UCLA: University of California, Los Angeles)H-Index: 10
#2Oscar Lilleby (UCPH: University of Copenhagen)H-Index: 1
Last. Amar U. Kishan (UCLA: University of California, Los Angeles)H-Index: 22
view all 4 authors...
Prostate cancer (PCa) is the most common noncutaneous solid organ malignancy among men worldwide. Radiation therapy is a standard of care treatment option that has historically been delivered in the form of small daily doses of radiation over the span of multiple weeks. PCa appears to have a unique sensitivity to higher doses of radiation per fraction, rendering it susceptible to abbreviated forms of treatment. Stereotactic body radiation therapy (SBRT) and high-dose-rate brachytherapy (HDRBT) a...
Source
#1Oscar Lilleby (UCPH: University of Copenhagen)H-Index: 1
#2Eivor Hernes (Oslo University Hospital)H-Index: 13
Last. Wolfgang Lilleby (Oslo University Hospital)H-Index: 18
view all 3 authors...
Abstract The side effects of androgen deprivation therapy (ADT) as general treatment against prostate cancer are known to impair quality of life. However, the optimal onset of ADT at PSA relapse is unknown, especially in patients with normal testosterone. In our case a limited PSMA avid lymph node was detected on PET/CT. Our case highlights the importance of metastasis-directed therapy balancing general versus tailored treatment in the decision making in the era of advanced molecular imaging. By...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.